Indications and Purposes
| 1 Indications And Usage Invirase In Combination With Ritonavir And Other Antiretroviral Agents Is Indicated For The Treatment Of Hiv-1 Infection In Adults (Over The Age Of 16 Years). The Following Points Should Be Considered When Initiating Therapy With Invirase/ritonavir: – The Twice Daily Administration Of Invirase In Combination With Ritonavir Is Supported By Safety Data From The Maxcmin 1 Trial [See Adverse Reactions (6.1) ] And Pharmacokinetic Data [See Clinical Pharmacology (12.3) ] . – The Efficacy Of Invirase With Ritonavir Has Not Been Compared Against The Efficacy Of Antiretroviral Regimens Currently Considered Standard Of Care. – The Number Of Baseline Primary Protease Inhibitor Mutations Affects The Virologic Response To Invirase/ritonavir. Invirase Is An Hiv-1 Protease Inhibitor Indicated For The Treatment Of Hiv-1 Infection In Combination With Ritonavir And Other Antiretroviral Agents In Adults (Over The Age Of 16 Years). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Saquinavir Mesylate |
|
ZINC3914596 |